Getinge Group net sales decrease 6.0% to SEK 5,241 for first quarter 2011

Getinge Group: (STO:GETIB)

Reporting period January - March

· Orders received declined by 6.0% to SEK 5,241 M (5,576), and grew organically by 1.1%

· Net sales declined by 3.9% to SEK 4,671 M (4,863), and grew organically by 3.2%

· Profit before tax rose by 3.1% to SEK 568 M (551) · Net profit increased by 5.0% to SEK 420 M (400)

· Earnings per share increased by 4.0% to SEK 1.75 (1.68)

· Continued favourable earnings outlook for 2011

First quarter 2011

Orders received The Group's organic orders received increased by 1.1% during the quarter. During the first quarter of the preceding year, a large order was registered for ventilators to Brazil for approximately SEK 250 M in Medical Systems. Adjusted for this order, the organic orders received amounted to slightly less than 6% for the period.

For Medical Systems, orders received declined organically by 2.0% as a result of the aforementioned order. For Extended Care and Infection Control, the organic orders received improved 1.7% and 7.4%, respectively.

From a geographic perspective, the Group's orders received developed according to plan although the Group's business areas exhibited some variation. Demand in Western Europe was unchanged compared with the year-earlier quarter while growth in North America was strong. Orders received in the emerging markets remained very favourable, taking the aforementioned Brazil order into account.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.